Leprosy reactions and nerve damage
- Tropical dermatology
Leprosy is curable, but sudden immune flare-ups called reactions can destroy nerves within days. Spotting them early prevents claw hands and blindness.
See it in 3D: Skin
What it is
Leprosy reactions are acute episodes of inflammation that interrupt the slow course of leprosy. They can occur before, during or years after multidrug therapy (MDT). Type 1 (reversal reaction) is a surge of cell-mediated immunity against Mycobacterium leprae antigens in borderline patients. Type 2 (erythema nodosum leprosum, ENL) is an immune-complex and neutrophil reaction in multibacillary patients (borderline lepromatous and lepromatous). Both can damage peripheral nerves fast, and nerve damage, not the bacteria, causes most of the disability of leprosy.
How to recognise it
- Type 1 (reversal): existing patches become red, swollen and sometimes ulcerate; new patches appear; hands, feet and face swell; nerves hurt and are tender; the patient is otherwise fairly well.
- Type 2 (ENL): crops of new, tender red nodules on face and limbs that come and go, with fever and malaise; also iritis, orchitis, arthritis, swollen fingers, enlarged nodes and kidney involvement.
- Neuritis is an emergency: pain or tenderness over a nerve, or new numbness or weakness; it can also be silent, with loss of function and no pain.
- Nerves to examine: ulnar (elbow), median (wrist), radial cutaneous, common fibular (knee), posterior tibial (ankle), facial and great auricular.
- Triggers: the first months of MDT, pregnancy and the months after delivery, infections, stress and vaccination.
- Lucio phenomenon: a rare necrotising reaction with purple, star-shaped ulcers in untreated diffuse lepromatous leprosy.
How it is confirmed
- The diagnosis is clinical: inflamed old patches suggest type 1; new nodules with fever suggest type 2. Compare with earlier notes and photos.
- Palpate each nerve for thickening and tenderness, comparing both sides.
- Test sensation with a monofilament on hands and feet, and strength of little finger, thumb, wrist, foot lift and eye closure.
- Record the results with the date: a change over weeks or months means active neuritis.
- In type 2 also check the eyes (red, painful eye, poor vision), testes, joints and urine.
- Skin smear or biopsy only if the type of reaction or a relapse is uncertain.
Type 1 vs type 2 reaction
| Feature | Type 1 (reversal) | Type 2 (ENL) |
|---|---|---|
| Who | Borderline patients (BT, BB, BL) | Multibacillary patients (BL, LL) |
| Mechanism | Cell-mediated (delayed hypersensitivity) | Immune complexes and neutrophils |
| Skin | Old lesions inflame and swell | New tender nodules in normal skin, may ulcerate |
| Whole body | Mild or none | Fever, malaise, eyes, testes, joints, kidneys |
| Nerves | Acute neuritis, common | Neuritis, often recurrent |
| Main treatment | Corticosteroids | Corticosteroids, thalidomide, clofazimine |
In Colombia
- Colombia still diagnoses a few hundred new leprosy cases a year, many with disability already present; leprosy is notifiable (SIVIGILA), and MDT and reaction drugs come from the national programme.
- MDT is never stopped during a reaction; the reaction is treated on top of it.
- Corticosteroids (prednisolone or prednisone) treat neuritis and type 1 reactions, as a long, slowly tapered course supervised by the programme.
- Thalidomide works very well in ENL but causes severe birth defects: it is given only within a controlled programme with strict pregnancy prevention, never in pregnancy. Clofazimine spares steroids in recurrent ENL.
- Teach self-care: daily look at hands, feet and eyes, protective footwear, and come back at once if a nerve hurts or strength or feeling changes.
Next step
- Any new nerve pain, numbness or weakness: assess for a reaction the same day.
- Before long steroid courses: screen for or treat strongyloidiasis, and check for diabetes, high blood pressure and tuberculosis.
- Before thalidomide: pregnancy test and contraception as the programme requires.
- Refer urgently to the leprosy programme or dermatology any neuritis, eye involvement, severe or recurrent ENL and Lucio phenomenon.
Common traps
- A reaction means MDT has failed or the bacteria are resistant: reactions are immune events, often triggered by MDT working; continue MDT.
- Painless nerves are safe nerves: silent neuritis destroys function without pain; test sensation and strength at every visit.
- ENL is the old leprosy patches flaring: ENL brings new nodules in normal-looking skin; inflamed old patches point to type 1.
- Thalidomide is just another anti-inflammatory: it causes severe limb and organ birth defects and is given only with strict pregnancy prevention.
- It is fine to wait and see whether neuritis settles: the nerve can be lost in days; steroids start promptly.
Test yourself
Think of the answer, then tap the question to see it.
Two months after starting MDT, a patient's old patches are red and swollen and his ulnar nerve is tender. What is happening and what is the priority?
A type 1 (reversal) reaction with neuritis; start corticosteroids promptly through the programme and continue MDT.
A lepromatous patient has fever, crops of tender red nodules on normal skin and a red, painful eye. Which reaction is this?
Type 2, erythema nodosum leprosum, an immune-complex reaction; the eye needs urgent ophthalmology review.
Why are sensation and strength tested at every visit even when the patient has no nerve pain?
Silent neuritis destroys nerve function without pain; only repeated testing catches early loss while steroids can still reverse it.
Elsewhere in DurgiPedia
- Leprosy in the skin: the patch that does not feel
- Infectious neuropathies: leprosy, diphtheria, zoster
Connections
See it in 3D1
The structures of Durgical's 3D anatomy where it is found.
Microorganisms1
In Pharmacology6
Educational content; it does not replace assessment by a doctor or dermatologist and is not a clinical instruction. For a rash with fever, painful skin, blisters or peeling, sores in the mouth or eyes, or a swelling throat, go to an emergency department at once.
Sources: Leprosy (StatPearls Publishing (NCBI Bookshelf), 2024); Thalidomide (StatPearls Publishing (NCBI Bookshelf), 2024); Leprosy (World Health Organization, 2024); Leprosy (Pan American Health Organization, 2024).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
